Poseida Therapeutics shares are trading higher after the company announced that it entered into a research collaboration and license agreement with Astellas to develop novel convertibleCAR programs.
Portfolio Pulse from Benzinga Newsdesk
Poseida Therapeutics' stock price increased following the announcement of a research collaboration and license agreement with Astellas for the development of novel convertibleCAR programs.
May 01, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Poseida Therapeutics' shares rose after announcing a collaboration with Astellas to develop novel convertibleCAR programs.
The announcement of a significant partnership with Astellas, a major player in the pharmaceutical industry, is likely to boost investor confidence in Poseida Therapeutics. This collaboration could potentially accelerate the development of their convertibleCAR programs, leading to positive market anticipation and an increase in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100